Eli Lilly Shows Obesity Drug Zepbound Can Treat Sleep Apnea Too
Eli Lilly drug tirzepatide, marketed as Zepbound for weight management, has results from two Phase 3 studies showing reductions in the breathing problems caused by obstructive sleep apnea. Lilly is now preparing regulatory submissions to add this indication to the drug’s label.
Want to Connect with Innovative Healthcare Startups and Investors? Register for MedCity INVEST Today!
In addition to panel discussions around some of the hottest topics in healthcare transformation, there is also a startup pitch contest, a presentation on government funding for startups and networking opportunities.
Star Ratings and Member Experience: Two Sides of the Same Coin
The challenge? Maintaining high Star Ratings or improving upon existing ratings gets increasingly difficult over time.
AHIP, AMA, NAACOS Release Playbook for Value-Based Care
AHIP, the AMA and NAACOS released a playbook last week that provides the best practices for value-based care. It is based on experiences from physicians, value-based care entities and payers.
Two Chairs Rakes In $72M For Its Hybrid Therapy Platform
Two Chairs, a startup offering hybrid behavioral health care, closed a $72 million Series C funding round. The company’s focus on measuring outcomes and dedication to care quality assurance are two key factors that differentiate it from other mental health startups, CEO Alex Katz said.